A CD1c lipid agnostic T cell receptor bispecific engager redirects T cells against CD1c+ cells
IntroductionImmunotherapy is emerging as an efficacious treatment for some cancers, complementing traditional chemo-radiation therapies. Specific markers at the cell surface of cancer cells can be used as immunotherapy targets. However, many of these m…